which is why ACEP changed their recommendations from "accidentally overtreating is a real thing, so maybe think twice before starting new meds" to "just start them on something if they have nothing."
My (huge, flashing, and flaming) concern is that htn is not supposed to be diagnosable by the standard criteria on a single elevated measurement or on those who are sick/in pain for the most part. So we are really *still* running afoul of the concern ACEP had from 2013 until earlier this year - that we might be starting a daily medication for a temporary BP rise and leading to iatrogenic hypertension. But I do trust, especially after reading their reasoning on it, that starting meds is more benefit than harm for most people and assume we can use some common sense to feel out where the patterns for 'this is temporary' vs 'this is htn' exist.